Trump Teases Major Autism Announcement Linked to Acetaminophen

WASHINGTON, D.C. — President Donald Trump announced on Sunday that he will reveal significant news regarding autism from the Oval Office on Monday. He described the upcoming announcement as “one of the most important news conferences I’ll ever have.”

While speaking at a memorial service for conservative activist Charlie Kirk, Trump hinted at possible new links between autism and the pain reliever Tylenol, which contains acetaminophen. “I think we found an answer to autism,” he stated, though he did not provide specific details about his forthcoming announcement.

A report from the Wall Street Journal earlier this month suggested that the announcement could address autism’s connection to acetaminophen use during pregnancy, highlighting the influence of low folate levels. Folate assists in proper brain and spine development in fetuses and is crucial during pregnancy.

Health officials reportedly plan to advise women against using Tylenol early during pregnancy unless necessary, according to the Washington Post. Kenvue, the maker of Tylenol, stated this month that mothers should consult their health care providers before taking any over-the-counter medication. The company emphasized that acetaminophen is considered the safest pain relief option for pregnant women.

In a statement, Kenvue reiterated its position by standing firm on existing research, asserting that over a decade of studies show no credible link between acetaminophen use and autism.

Experts have echoed this sentiment. Dr. Christopher Zahn, of the American College of Obstetricians and Gynecologists, noted, “There is no clear evidence that proves a direct relationship between the prudent use of acetaminophen during pregnancy and fetal developmental issues.”

The announcement comes amidst rising autism diagnoses in the U.S., with the Centers for Disease Control and Prevention reporting that about 1 in 31 children were diagnosed with autism by age 8 in 2022, an increase from 1 in 36 in 2020. This rise has been attributed to broader diagnostic criteria and improved screening practices.

While some studies have suggested potential associations between acetaminophen use during pregnancy and autism, many experts caution that the science is still unsettled. Some studies, including one analyzing over 2 million children in Sweden, found no increased autism risk linked to maternal acetaminophen use.

HHS Secretary Robert F. Kennedy Jr. has previously made controversial claims connecting vaccine use to autism and indicated that new findings about autism’s causes would be presented in September.

Dr. Peter Hotez, a pediatrician, expressed skepticism about making broad claims regarding Tylenol without comprehensive evidence. He labeled the connection as “not terribly compelling” and highlighted the multifactorial nature of neurodevelopmental disorders.

As anticipation builds for Monday’s press conference, health professionals continue to emphasize safety and informed decision-making for pregnant women.